Flexterity

Medical

Free

Flexterity is a physiotherapy tool and should only be used under the guidance of a physiotherapist. Created and funded by Novartis. Flexterity has been designed to help parents and caregivers of children with neuromuscular disorders. Your child’s specialist physiotherapist can create a tailored programme of exercises to suit the age and physical ability of your child and adapt these to their progress. The exercises are demonstrated in short videos accompanied by easy to follow instructions which you and your child can follow. Working with Specialist Neuromuscular Physiotherapists and healthcare experts, Flexterity aims to provide exercises to help the flexibility, movement and muscle control of children with neuromuscular diseases. January 2022 UK-UNB-22-0016 V2

  • This app has not received enough ratings or reviews to display an overview.

Updated screenshots

The developer, Novartis Pharma AG, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Not Collected

    The developer does not collect any data from this app.

    Privacy practices may vary based, for example, on the features you use or your age. Learn More

    The developer has not yet indicated which accessibility features this app supports. Learn More

    • Size
      • 41.2 MB
    • Category
      • Medical
    • Compatibility
      Requires iOS 13.0 or later.
      • iPhone
        Requires iOS 13.0 or later.
      • iPad
        Requires iPadOS 13.0 or later.
      • iPod touch
        Requires iOS 13.0 or later.
      • Apple Vision
        Requires visionOS 1.0 or later.
    • Languages
      • English
    • Age Rating
      13+
      • 13+
      • Infrequent
        Medical Treatment Information
    • Provider
      Novartis Pharma AG
      • Novartis Pharma AG has not identified itself as a trader for this app. If you are a consumer in the European Economic Area, consumer rights do not apply to agreements between you and the provider.
    • Copyright
      • © 2022 Novartis